GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Live Q&A - 24 September 2020 - 15:30-16:00
Date
22 Sep 2020Session
GSK - Update on the evolving landscape for endometrial cancer treatment with ImmunotherapyPresenters
Ana OakninAuthors
A. OakninAuthor affiliations
- Medical Oncology Dept., Vall d`Hebron University Hospital Institut d'Oncologia, 8035 - Barcelona/ES
Resources
Resources from the same session
Welcome and Introduction
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Patient journeys of 2 women with recurrent/advanced EC
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Monotherapy checkpoint inhibitor studies in recurrent endometrial cancer
Presenter: Renaud Sabatier
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Evolution of diagnosis and classification of endometrial cancer and emergence of molecular classification
Presenter: Amit Oza
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Endometrial cancer as an attractive target for checkpoint inhibitor-based therapy
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Conclusion
Presenter: Robert Coleman
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
Combination checkpoint inhibitor studies in newly diagnosed and recurrent endometrial cancer
Presenter: Ana Oaknin
Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.